Company Number: 12814058

Analysis Date: 2025-07-20 15:19 UTC

Financial Health Assessment of CRYOLABSMOBILE LIMITED

---

1. Financial Health Score: C

Explanation:
Cryolabsmobile Limited demonstrates moderate financial stability but exhibits key symptoms of liquidity stress. The company has positive net assets and shareholder equity, indicating some underlying value and solvency. However, the persistent negative net current assets (working capital deficit) and reliance on long-term liabilities suggest challenges with short-term cash flow management. The score “C” reflects a fair financial condition with notable caution signals that require attention.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets	£359,259	Strong investment in long-term assets; capital intensive business model.
Current Assets	£59,983	Significantly low compared to liabilities; risk of cash flow issues.
Current Liabilities	£359,489	Very high short-term obligations; potential liquidity strain.
Net Current Assets	-£299,506	Negative working capital; "symptom of distress" in day-to-day operations.
Net Assets (Equity)	£37,463	Positive but low equity cushion; solvency is maintained.
Share Capital	£800	Minimal share capital; limited equity funding base.
Long-term Liabilities	£22,290	Moderate long-term debt; manageable but adds to financial burden.
Average Employees	4	Small team; micro-business scale.

Interpretation:

• The company’s strong fixed asset base shows commitment to operational capacity, likely specialized equipment or facilities related to health activities and research.
• Current liabilities outweigh current assets by a large margin, signaling potential difficulties in meeting immediate financial obligations—akin to a patient with a weak pulse in cash flow.
• Positive net assets indicate the company is not insolvent but has a thin equity margin that could be eroded if losses occur.
• The small share capital and micro-accounting category confirm the company's small scale, which limits financial flexibility.

---

3. Diagnosis: Overall Financial Condition

Cryolabsmobile Limited is currently solvent but exhibits symptoms of liquidity distress. Negative working capital over multiple years points to ongoing cash flow challenges that may threaten the company’s ability to cover short-term debts without resorting to additional borrowing or asset liquidation. The company’s financial "vital signs" suggest it is dependent on maintaining or increasing cash inflows or restructuring liabilities.

The relatively stable but low net asset value and incremental growth in fixed assets imply the company is investing in its core business, consistent with its SIC classifications in health activities and research. However, this investment comes with increased financial strain due to insufficient liquid resources.

In medical terms, the company is like a patient with stable but fragile health—solvent but vulnerable to acute financial "stress episodes" unless liquidity improves.

---

4. Prognosis: Future Financial Outlook

• Without improved cash flow management or capital injection, the company risks worsening liquidity problems, which could lead to delayed payments, strained supplier relationships, or challenges in sustaining operations.
• The next 12-18 months will be critical; if working capital improves (through increased revenues, better receivables management, or refinancing), the prognosis could be stable to positive.
• Conversely, if liquidity issues persist or worsen, the company may face operational restrictions or require restructuring—similar to a patient needing intervention to prevent decline.

---

5. Recommendations: Specific Actions to Improve Financial Wellness

• Enhance Cash Flow Management:
  Prioritize collection of receivables and negotiate extended payment terms with creditors to reduce immediate cash outflows. Consider cash flow forecasting to anticipate liquidity gaps.

• Explore Capital Injection:
  Seek equity investment or shareholder loans to strengthen the capital base, improving financial resilience and reducing reliance on short-term liabilities.

• Cost Control and Efficiency:
  Review operating expenses and fixed asset utilization to ensure investments generate adequate returns. Avoid unnecessary capital expenditures until liquidity improves.

• Debt Restructuring:
  Engage with creditors to restructure short-term debts into longer maturities, easing immediate cash pressure.

• Monitor Financial Metrics Regularly:
  Implement regular financial health checks focusing on liquidity ratios (current ratio, quick ratio) and working capital trends to detect early warning signs.

• Business Development Focus:
  Leverage core competencies in human health activities and research to grow revenues, improving cash inflows and overall financial stability.

---